SCHEMBL4777319

SCHEMBL4777319

O=C(CNc1cc(-c2cccnc2)nc(-c2ccccn2)n1)c1c[nH]c2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 1/20 0.47
CCND1 P24385 1/20 0.47
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
NR4A2 P43354 1/20 0.41
GBA1 P04062 1/20 0.41
CTNNB1 P35222 1/20 0.41
WNT3A P56704 1/20 0.41
CCNE1 P24864 1/20 0.40
CDK2 P24941 1/20 0.40
CYP3A4 P08684 3/20 0.40
CYP2C9 P11712 2/20 0.40
BACE1 P56817 2/20 0.40
KDR P35968 1/20 0.40
CYP2A6 P11509 1/20 0.39
USP2 O75604 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C19 P33261 2/20 0.39
CLK4 Q9HAZ1 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3962080 0.83 CDK4 (0.58) CDK4CCND1MEN1KMT2AGBA1
SCHEMBL2240341 0.83 CDK4 (0.50) CDK4CCND1MEN1KMT2AGBA1
SCHEMBL4776165 0.80 CCKBR (0.52) CDK4CCND1MEN1KMT2AGBA1
SCHEMBL2240556 0.79 CYP3A4 (0.41) CDK4CCND1MEN1KMT2AGBA1
SCHEMBL4769102 0.79 KMT2A (0.55) CDK4CCND1MEN1KMT2AGBA1
SCHEMBL2240652 0.78 CYP1A2 (0.53) CDK4CCND1MEN1KMT2AGBA1
SCHEMBL2244808 0.78 SPR (0.59) CDK4CCND1MEN1KMT2AGBA1
SCHEMBL4776020 0.77 CDK4 (0.49) CDK4CCND1MEN1KMT2ASCN9A
SCHEMBL2238410 0.77 CYP1A2 (0.53) CDK4CCND1MEN1KMT2AGBA1
SCHEMBL2241460 0.76 CDK4 (0.47) CDK4CCND1MEN1KMT2AGBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1878733-A1 Pyrimidine derivatives as ALK-5 inhibitors Novartis AG (CH) 2008-01-16 EP disclosed